NCT06878105 Patient Blood Management Implementation in CEE Study
| NCT ID | NCT06878105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Semmelweis University |
| Condition | Anemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-05-27 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-05-27 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the study is data collection on available fixed and personal assets required for Patient Blood Management (elements of the 3 pillars of PBM) in Central Eastern Europe countries hospitals, status before and after PBM training.
Eligibility Criteria
Inclusion Criteria: * patients above 18 years of age * patients undergoing elective medium and high bleeding risk surgical intervention defined as moderate (\<500 ml) and high (≥ 500 ml) * patient consent Exclusion Criteria: * no patient consent * patients under 18 years of age * pregnant patients * surgery with a low risk of bleeding * the patient underwent emergency (non-elective) surgery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06878105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06878105 currently recruiting?
Yes, NCT06878105 is actively recruiting participants. Contact the research team at jancsidora@gmail.com for enrollment information.
Where is the NCT06878105 trial being conducted?
This trial is being conducted at Budapest, Hungary.
Who is sponsoring the NCT06878105 clinical trial?
NCT06878105 is sponsored by Semmelweis University. The trial plans to enroll 2,000 participants.